OBJECTIVE: To determine if, and at what point, glaucoma affects spoken reading speed. METHODS: Data were collected from the Salisbury Eye Evaluation, a population-based evaluation of visual function and disability in the elderly population. Nonscrolling text was displayed on a screen and the rate words were read aloud was measured. Subjects reading slower than 90 words/min were defined as having impairment. Glaucoma status was determined using optic disc appearance and visual field testing. RESULTS: One thousand one hundred fifty-four subjects completed evaluations of spoken reading speed and glaucoma status. Univariate analysis demonstrated reading impairment in 16.0% of subjects without glaucoma, 21.1% of subjects with unilateral glaucoma (P = .25), and 28.4% of subjects with bilateral glaucoma (P = .006). Multivariable regression demonstrated nonsignificant increases in the odds of reading impairment for subjects with unilateral (odds ratio, [OR], 1.13; P = .69) and bilateral glaucoma (OR, 1.25; P = .43), though subjects with bilateral glaucoma in the highest quartile of better-eye visual field loss read slower (beta = -32 words/min; P = .01) and were more often reading impaired than controls without glaucoma (OR, 3.8; P = .04). Race, cognitive ability, education, and visual acuity were important predictors of reading impairment. CONCLUSIONS: High rates of spoken reading impairment were found throughout this elderly sample. Glaucoma was associated with slower reading and increased reading impairment with advanced bilateral field loss.
OBJECTIVE: To determine if, and at what point, glaucoma affects spoken reading speed. METHODS: Data were collected from the Salisbury Eye Evaluation, a population-based evaluation of visual function and disability in the elderly population. Nonscrolling text was displayed on a screen and the rate words were read aloud was measured. Subjects reading slower than 90 words/min were defined as having impairment. Glaucoma status was determined using optic disc appearance and visual field testing. RESULTS: One thousand one hundred fifty-four subjects completed evaluations of spoken reading speed and glaucoma status. Univariate analysis demonstrated reading impairment in 16.0% of subjects without glaucoma, 21.1% of subjects with unilateral glaucoma (P = .25), and 28.4% of subjects with bilateral glaucoma (P = .006). Multivariable regression demonstrated nonsignificant increases in the odds of reading impairment for subjects with unilateral (odds ratio, [OR], 1.13; P = .69) and bilateral glaucoma (OR, 1.25; P = .43), though subjects with bilateral glaucoma in the highest quartile of better-eye visual field loss read slower (beta = -32 words/min; P = .01) and were more often reading impaired than controls without glaucoma (OR, 3.8; P = .04). Race, cognitive ability, education, and visual acuity were important predictors of reading impairment. CONCLUSIONS: High rates of spoken reading impairment were found throughout this elderly sample. Glaucoma was associated with slower reading and increased reading impairment with advanced bilateral field loss.
Authors: John L Keltner; Chris A Johnson; Kimberly E Cello; Shannan E Bandermann; Juanjuan Fan; Richard A Levine; Michael A Kass; Mae O Gordon Journal: J Glaucoma Date: 2007-12 Impact factor: 2.503
Authors: Karen Glanz; Allen D Beck; Lucja Bundy; Susan Primo; Michael J Lynn; Julia Cleveland; Jessica A Wold; Katharina V Echt Journal: Arch Ophthalmol Date: 2012-10
Authors: Karun S Arora; Michael V Boland; David S Friedman; Joan L Jefferys; Sheila K West; Pradeep Y Ramulu Journal: Ophthalmology Date: 2013-08-30 Impact factor: 12.079
Authors: Priya M Mathews; Pradeep Y Ramulu; David S Friedman; Canan A Utine; Esen K Akpek Journal: Ophthalmology Date: 2013-05-25 Impact factor: 12.079
Authors: Pradeep Y Ramulu; Bonnielin K Swenor; Joan L Jefferys; David S Friedman; Gary S Rubin Journal: Invest Ophthalmol Vis Sci Date: 2013-01-23 Impact factor: 4.799
Authors: Angeline M Nguyen; Suzanne W van Landingham; Robert W Massof; Gary S Rubin; Pradeep Y Ramulu Journal: Invest Ophthalmol Vis Sci Date: 2014-07-22 Impact factor: 4.799